Skip to main content

Advertisement

SpringerLink
Log in

Interaction between tissue factor pathway inhibitor-2 gene polymorphisms and environmental factors associated with coronary atherosclerosis in a Chinese Han

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Abstract

To investigate the association of single nucleotide polymorphisms (SNPs) within tissue factor pathway inhibitor-2 (TFPI-2) gene polymorphisms and additional gene–environment interaction with coronary atherosclerosis risk. Generalized multifactor dimensionality reduction (GMDR) was used to screen the best interaction combination among 4 SNPs, smoking and alcohol drinking. Logistic regression was performed to investigate association between 4 SNPs within TFPI-2 gene and coronary atherosclerosis risk. Coronary atherosclerosis risk was significantly higher in carriers with the A allele of rs34489123 within TFPI-2 gene than those with GG genotype (GA+AA versus GG), adjusted OR (95% CI) = 1.70 (1.20–2.31), and was also higher in carriers with the G allele of rs4264 within TFPI-2 gene than those with AA genotype (AG+GG versus AA), adjusted OR (95% CI) = 1.62 (1.21–2.11). GMDR model shown the best models for gene–environment interaction were rs34489123 and smoking after adjusting the covariates, which scored 10 out of 10 for cross-validation consistency and 0.0010 for the sign test. Heavy LD was found for SNPs rs34489123 and rs59805398 (D’ value was more than 0.8). Compared to control individuals, the AG haplotypes appeared to be significantly associated with increased coronary atherosclerosis risk, OR (95% CI) = 1.73 (1.22–2.32). We found that the A allele of rs34489123 and the G allele of rs4264 within TFPI-2 gene, interaction between rs34489123 and smoking and AG haplotypes were all associated with increased coronary atherosclerosis risk.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Mannarino E, Pirro M (2008) Molecular biology of atherosclerosis. Clin Cases Miner Bone Metab 5:57–62

    PubMed  PubMed Central  Google Scholar 

  2. Davignon J, Ganz P (2004) Role of endothelial dysfunction in atherosclerosis. Circulation 109(23 Suppl 1):SIII–S27

    Google Scholar 

  3. Hansson GK, Robertson AK, Söderberg–Nauclér C (2006) Inflammation and atherosclerosis. Annu Rev Pathol 1:297–329

    Article  CAS  PubMed  Google Scholar 

  4. Rath M, Niendorf A, Reblin T, Dietel M, Krebber HJ, Beisiegel U (1989) Detection and quantification of lipoprotein (a) in the arterial wall of 107 coronary bypass patients. Arteriosclerosis 9:579–592

    Article  CAS  PubMed  Google Scholar 

  5. Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352:1685–1695

    Article  CAS  Google Scholar 

  6. Cooper R, Cutler J, Desvigne-Nickens P, Fortmann SP, Friedman L, Havlik R, Hogelin G, Marler J, McGovern P, Morosco G, Mosca L, Pearson T, Stamler J, Stryer D, Thom T (2000) Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention. Circulation 102(25):3137–3147

    Article  Google Scholar 

  7. Rollin J, Iochmann S, Blechet C, Hube F, Regina S, Guyetant S, Lemarie E, Reverdiau P, Gruel Y (2005) Expression and methylation status of tissue factor pathway inhibitor-2 gene in non-small-cell lung cancer. Br J Cancer 92:775–783

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Zhao B, Luo X, Shi H, Ma D (2011) Tissue factor pathway inhibitor-2 is downregulated by ox-LDL and inhibits ox-LDL induced vascular smooth muscle cells proliferation and migration. Thromb Res 128:179–185

    Article  CAS  PubMed  Google Scholar 

  9. Xu Z, Maiti D, Kisiel W, Duh EJ (2006) Tissue factor pathway inhibitor-2 is upregulated by vascular endothelial growth factor and suppresses growth factor-induced proliferation of endothelial cells. Arterioscler Thromb Vasc Biol 26:2819–2825

    Article  CAS  PubMed  Google Scholar 

  10. Ivanciu L, Gerard RD, Tang H, Lupu F, Lupu C (2007) Adenovirus-mediated expression of tissue factor pathway inhibitor-2 inhibits endothelial cell migration and angiogenesis. Arterioscler Thromb Vasc Biol 27:310–316

    Article  CAS  PubMed  Google Scholar 

  11. Dong Y, Tan Q, Tao L, Pan X, Pang L, Liang W, Liu W, Zhang W, Li F, Jia W (2015) Hypermethylation of TFPI2 correlates with cervical cancer incidence in the Uygur and Han populations of Xinjiang, China. Int J Clin Exp Pathol 8(2):1844–1854

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Zhao BL, Liu HY, Ni HC, Luo X, Li J, Jin B, Zhu J, Li Y, Shen W, Shi H (2012) Changes of plasma tissue factor and tissue factor pathway inhibitor 2 levels in elderly patients with acute coronary syndrome. Shanghai Med 35:779–783

    CAS  Google Scholar 

  13. Yu J, Liu RL, Luo XP, Shi HM, Ma D, Pan JJ, Ni HC (2015) Tissue factor pathway inhibitor-2 gene polymorphisms associate with coronary atherosclerosis in Chinese population. Medicine (Baltimore) 94(42):e1675

    Article  CAS  Google Scholar 

  14. Li YF, Hsiao YH, Lai YH, Chen YC, Chen YJ, Chou JL, Chan MW, Lin YH, Tsou YA, Tsai MH, Tai CK (2015) DNA methylation profiles and biomarkers of oral squamous cell carcinoma. Epigenetics 10(3):229–236

    Article  PubMed  PubMed Central  Google Scholar 

  15. Chen JJ, Wang AQ, Chen QQ (2017) DNA methylation assay for colorectal carcinoma. Cancer Biol Med 14(1):42–49

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Arakawa N, Kobayashi H, Yonemoto N, Masuishi Y, Ino Y, Shigetomi H, Furukawa N, Ohtake N, Miyagi Y, Hirahara F, Hirano H, Miyagi E (2016) Clinical significance of tissue factor pathway inhibitor 2, a serum biomarker candidate for ovarian clear cell carcinoma. PLoS ONE 11(10):e0165609

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Pan JJ, Shi HM, Luo XP, Ma D, Li Y, Zhu J, Liang W, Mu JG, Li J (2011) Recombinant TFPI-2 enhances macrophage apoptosis through upregulation of Fas/FasL. Eur J Pharmacol 654:135–141

    Article  CAS  PubMed  Google Scholar 

  18. Pan J, Ma D, Sun F, Liang W, Liu R, Shen W, Wang H, Ji Y, Hu R, Liu R, Luo X, Shi H (2013) Over-expression of TFPI-2 promotes atherosclerotic plaque stability by inhibiting MMPs in apoE-/- mice. Int J Cardiol 168:1691–1697

    Article  PubMed  Google Scholar 

  19. Siegling S, Thyzel E, Glahn J, Kleesiek K, Götting C (2006) Analysis of sequence variations in the promoter region of the human tissue factor pathway inhibitor 2 gene in apoplectic patients and blood donors. Ann Hematol 85:32–37

    Article  CAS  PubMed  Google Scholar 

  20. Hube F, Reverdiau P, Iochmann S, Cherpi-Antar C, Gruel Y (2003) Characterization and functional analysis of TFPI-2 gene promoter in a human choriocarcinoma cell line. Thromb Res 109:207–215

    Article  CAS  PubMed  Google Scholar 

  21. Mino K, Nishimura S, Ninomiya S, Tujii H, Matsumori Y, Tsuchida M, Hosoi M, Koseki K, Wada S, Hasegawa M, Sasaki R, Murakami-Yamaguchi Y, Narita H, Suzuki T, Miyata N, Mizukami T (2014) Regulation of tissue factor pathway inhibitor-2 (TFPI-2) expression by lysine-specific demethylase 1 and 2 (LSD1 and LSD2). Biosci Biotechnol Biochem 78:1010–1017

    Article  CAS  PubMed  Google Scholar 

  22. Zawadzki C, Chatelain N, Delestre M, Susen S, Quesnel B, Juthier F, Jeanpierre E, Azzaoui R, Corseaux D, Breyne J, Torpier G, Staels B, Van Belle E, Jude B (2009) Tissue factor pathway inhibitor-2 gene methylation is associated with low expression in carotid atherosclerotic plaques. Atherosclerosis 204:e4–e14

    Article  CAS  PubMed  Google Scholar 

  23. Kim JA, Chun EJ, Lee MS, Kim KJ, Choi SI (2013) Relationship between amount of cigarette smoking and coronary atherosclerosis on coronary CTA in asymptomatic individuals. Int J Cardiovasc Imaging 29(Suppl 1):21–28

    Article  PubMed  Google Scholar 

  24. Jia EZ, Liang J, Yang ZJ, Zhu TB, Wang LS, Chen B, Cao KJ, Huang J, Ma WZ (2009) Smoking and coronary atherosclerosis: follow-up study in China. Clin Exp Pharmacol Physiol 36(7):690–695

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank the investigators and staffs from Longhua District Central Hospital and Mudanjiang second People’s Hospital, and all the partners who help us in the process of this study. Hairong Zhou and Yanjuan Che contributed equally to this work.

Author information

Author notes

  1. Hairong Zhou and Yanjuan Che have contributed equally to this work.

Authors and Affiliations

  1. Department of General Medicine, Longhua District Central Hospital, Shenzhen, 518110, China

    Hairong Zhou, Yanxuan Chen & Shaopeng Zhang

  2. Department of Cardiovascular Medicine, Mudanjiang Second People’s Hospital, Mudanjiang, 15700, China

    Yanjuan Che, Xiuhua Fu, Hong Wei & Xiuying Gao

Authors
  1. Hairong Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yanjuan Che
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xiuhua Fu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hong Wei
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xiuying Gao
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yanxuan Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Shaopeng Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xiuhua Fu.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhou, H., Che, Y., Fu, X. et al. Interaction between tissue factor pathway inhibitor-2 gene polymorphisms and environmental factors associated with coronary atherosclerosis in a Chinese Han. J Thromb Thrombolysis 47, 67–72 (2019). https://doi.org/10.1007/s11239-018-1755-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11239-018-1755-6

Keywords

Search

Navigation